Cocaine

Stimulantintranasal (insufflated) · inferred

Tropane alkaloid and potent CNS stimulant that blocks dopamine, serotonin, and norepinephrine reuptake. Very short half-life (~1 hour) but primary metabolite benzoylecgonine persists ~6 hours and is the standard urine test target, detectable for 2-4 days.

Projected serum levels — 1 lines (≈ 50 mg), as needed (shown daily)

Cocaine
Cocaine modeled serum levels, 1 lines (≈ 50 mg) as needed (shown daily) over 15 days Population-based pharmacokinetic estimate. Steady state reached after approximately 1 days. 0 5 10 15 20 Day 0 Day 4 Day 8 Day 11 Day 15 Time on a regular schedule ≈ steady state · day 1

Maintenance schedule: 1 lines (≈ 50 mg) as needed (shown daily) (intranasal (insufflated)).

Modeled steady state after ~1 days: peak ≈ 13.4 mg, trough ≈ 0.000 mg body load. Population-based estimate over 15 days for a reference dose at a 70 kg reference body mass — the interactive app scales curves to your doses, timing, and body mass.

Key facts

Category
Stimulant
Route modeled
Intranasal (insufflated)
Model confidence
inferred
Half-life
1 h
Common dose
1 lines (≈ 50 mg)
Reference dose range
0.50–2 lines (single dose)
Suggested cadence
as needed (shown daily)
Validated against
100 mg insufflated — Cmax 0.20 mg/L at 0.50 h

Documented interactions

  • danger
    1P-LSD (1-Propionyl-LSD) + Cocaine Serotonin risk

    1P-LSD (1-Propionyl-LSD) and Cocaine both have serotonergic activity. Risk of serotonin syndrome (hyperthermia, rigidity, autonomic instability, altered mental status).

  • danger
    25I-NBOMe + Cocaine Serotonin risk

    25I-NBOMe and Cocaine both have serotonergic activity. Risk of serotonin syndrome (hyperthermia, rigidity, autonomic instability, altered mental status).

  • danger
    2C-I (2,5-Dimethoxy-4-iodophenethylamine) + Cocaine Serotonin risk

    2C-I (2,5-Dimethoxy-4-iodophenethylamine) and Cocaine both have serotonergic activity. Risk of serotonin syndrome (hyperthermia, rigidity, autonomic instability, altered mental status).

  • danger
    2C-B (4-Bromo-2,5-dimethoxyphenethylamine) + Cocaine Serotonin risk

    2C-B (4-Bromo-2,5-dimethoxyphenethylamine) and Cocaine both have serotonergic activity. Risk of serotonin syndrome (hyperthermia, rigidity, autonomic instability, altered mental status).

  • danger
    4-AcO-DMT (Psilacetin) + Cocaine Serotonin risk

    4-AcO-DMT (Psilacetin) and Cocaine both have serotonergic activity. Risk of serotonin syndrome (hyperthermia, rigidity, autonomic instability, altered mental status).

  • danger
    5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine) + Cocaine Serotonin risk

    5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine) and Cocaine both have serotonergic activity. Risk of serotonin syndrome (hyperthermia, rigidity, autonomic instability, altered mental status).

Serum checks 175 modeled interaction pairings for cocaine across your whole stack — absorption conflicts, enzyme inhibition, and nutrient depletion included.

Research behind this entry

  1. Pharmacokinetics and Pharmacodynamics of Cocaine Cone EJ · Journal of Analytical Toxicology, 1995 DOI

    Compared cocaine pharmacokinetics across IV (25 mg), intranasal (32 mg), and smoked (42 mg) routes in six subjects, characterizing benzoylecgonine formation and elimination by each route.

  2. Pharmacokinetics of Cocaine and Metabolites in Human Oral Fluid and Correlation with Plasma Concentrations following Controlled Administration Jufer RA et al. · Journal of Analytical Toxicology, 2006 DOI

    Determined disposition of cocaine, benzoylecgonine, and ecgonine methyl ester in oral fluid following subcutaneous cocaine, with BE half-lives of 3.4-13.8 hours.

  3. A Sensitive Assay for Urinary Cocaine Metabolite Benzoylecgonine Shows More Positive Results and Longer Half-Lives than Those Using Traditional Cut-Offs Preston KL et al. · Drug and Alcohol Dependence, 2017 DOI

    Demonstrated that using lower assay cutoffs reveals longer benzoylecgonine detection windows in urine, with terminal half-life estimates significantly longer than previously reported.

3 published studies referenced in the app, each with a plain-language summary.